A new lenalidomide–quercetin cocrystal developed with mechanochemistry

IMPACTIVE has achieved another milestone thanks to mechanochemistry. We’ve synthesised a new cocrystal of the anticancer drug lenalidomide with quercetin, a potent antioxidative compound.

IMPACTIVE
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.